IPO Listed

Avalyn Pharma IPO

US$300m raised

Lodged 29 Apr 2026 · NASDAQ: AVLN

Advisers

Avalyn Pharma

Issuer

Legal adviser
Issuer
Avalyn Pharma
Issuer based in
United States
Listed
30 Apr 2026
Sector
Biotech
Tags
Biotech, Pharma, Rare Disease

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.